Chicago Equity Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,124
Closed -$260K 825
2016
Q2
$260K Buy
6,124
+148
+2% +$6.28K 0.01% 579
2016
Q1
$394K Sell
5,976
-9,781
-62% -$645K 0.01% 509
2015
Q4
$979K Buy
15,757
+302
+2% +$18.8K 0.03% 363
2015
Q3
$1.04M Buy
15,455
+13,417
+658% +$899K 0.03% 356
2015
Q2
$198K Sell
2,038
-1,514
-43% -$147K 0.01% 452
2015
Q1
$332K Buy
3,552
+810
+30% +$75.7K 0.01% 377
2014
Q4
$244K Sell
2,742
-2,274
-45% -$202K 0.01% 361
2014
Q3
$346K Buy
5,016
+3,399
+210% +$234K 0.01% 360
2014
Q2
$92K Buy
+1,617
New +$92K ﹤0.01% 434